SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹65 Cr | ₹58 Cr | ₹54 Cr | ₹31 Cr | ₹28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹65 Cr |
Mar2023 | ₹58 Cr |
Mar2022 | ₹54 Cr |
Mar2021 | ₹31 Cr |
Mar2020 | ₹28 Cr |
How is Deferred Tax Assets / Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹65 Cr | 11.26 | |
Mar2023 | ₹58 Cr | 7.22 | |
Mar2022 | ₹54 Cr | 75.59 | |
Mar2021 | ₹31 Cr | 12.09 | |
Mar2020 | ₹28 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹41,399.2 Cr | 5.1% | 9.4% | 27.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 5.1% |
9.4% |
27.4% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses